tbuckley/cabot-search huggingface dataset:
Monitoring liver transplant rates in persons diagnosed with hepatitis C: a data linkage study, England 2008 to 2017
Authors: G Ireland, R Simmons, M Hickman, M Ramsay, C Sabin, S Mandal
Journal: Eurosurveillance (2019)

IntroductionLiver transplantation is an important measure of burden from hepatitis C virus (HCV)-associated liver disease.AimsTo describe transplant rates and survival in individuals with HCV infection from 2008 to 2017 in England through data linkage.MethodsThis is a retrospective observational cohort study. Laboratory reports of HCV infection were linked to the Liver Transplant Registry for individuals aged 15 years and over, first diagnosed between 1998 and 2017. We estimated age-sex standardised incidence rates and used Poisson regression to investigate predictors of liver transplantation and test for a change in incidence after introduction of direct-acting antivirals (DAAs) in 2014. Kaplan-Meier survival analysis was used to calculate post-transplant survival rates.ResultsOf 124,238 individuals diagnosed with HCV infection, 1,480 were registered and 1,217 received a liver transplant. Of individuals registered, 1,395 had post-HCV cirrhosis and 636 had hepatocellular carcinoma (618 also had post-HCV cirrhosis). Median time from HCV diagnosis to transplant was 3.4 years (interquartile range: 1.3-6.8 years). Liver transplant rates were lower 2014-17 compared with 2011-13 (incidence rate ratio: 0.64; 95% confidence interval: 0.55-0.76). Survival rates were 93.4%, 79.9% and 67.9% at 1, 5 and 10 years, respectively. Data linkage showed minimal under-reporting of HCV in the transplant registry.ConclusionIn the post-DAA era, liver transplant rates have fallen in individuals with HCV infection, showing early impact of HCV treatment scale-up; but the short time from HCV diagnosis to liver transplant suggests late diagnosis is a problem.
A New Strategy Of MDS Treatment With Azacitidine (AZA): Induction With AZA Combined With Low Dose AraC Followed By Maintenance Therapy With AZA
Authors: Manabu Hirai, Takahiko Nakane, Atsushi Inoue, Mitsuharu Hashimura, Mizuki Aimoto, Erina Sakamoto, Hirohisa Nakamae, Masayuki Hino
Journal: Blood (2013)
Use of Jak2 Inhibitors to Limit Ineffective Erythropoiesis and Iron Absorption in Mice Affected by β-Thalassemia and Other Disorders of Red Cell Production.
Authors: Luca Melchiori, Sara Gardenghi, Ella C. Guy, Eliezer Rachmilewitz, Patricia J Giardina, Robert W. Grady, Mohandas Narla, Xiuli An, Stefano Rivella
Journal: Blood (2009)
Novel Risk Factors for Predicting the Development of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Undergoing Induction and Re-Induction Chemotherapy
Authors: Mohammed Athar Naeem, Amy L Morris, Mark Smolkin, Torrey Murray, Jessica D Lewis, Kathlene DeGregory, Tanya Thomas, Anjali Bal, Michael K. Keng
Journal: Blood (2016)
Abnormal Expression of Ndfip2 and Cbl in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: Role of Ubiquitin Proteasome System in Myeloid Neoplasms and Normal Hematopoiesis
Authors: Fernando V Pericole, Joao Machado-Neto, Fernando Ferreira Costa, Sara T Olalla Saad
Journal: Blood (2011)
Inhibition of Syk Activity Is Sufficient for Inhibitory Effect in Animal Models of Autoimmune Diseases
Authors: Stanley J Hollenbach, Greg Coffey, Francis R DeGuzman, Mayuko Inagaki, Anjali Pandey, Zhaozhong J Jia, Qing Xu, Shawn Bauer, Dale Baker, Nisha Nanda, David R Phillips, Uma Sinha
Journal: Blood (2008)
Incidence and Outcomes of Chronic Myeloid Leukemia (CML) Patients (pts) with Other Chromosomal Abnormalities (OCA) Treated with Second Generation Tyrosine Kinase Inhibitors (TKI)
Authors: Naveen Pemmaraju, Hagop M. Kantarjian, Elias J. Jabbour, Alfonso Quintás-Cardama, Gautam Borthakur, Elizabeth M Burton, Sara E Dellasala, Sherry A. Pierce, Steven M. Kornblau, Srdan Verstovsek, Susan O'Brien, Jorge E. Cortes
Journal: Blood (2012)
MYC-ID3 Pathway in a Cohort of Diffuse Large B Cell Lymphomas: Immunoistochemical Analysis and Prognostic Implications
Authors: Elisa Doni, Fabio Pagni, Fausto Rossini, Angelo Belotti, Silvia Bolis, Ivana Casaroli, Giorgio Cattoretti, Pietro Enrico Pioltelli, Carlo Gambacorti-Passerini
Journal: Blood (2016)
B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior
Authors: Hideto Tamura, Mariko Ishibashi, Taishi Yamashita, Asaka Kondo, Namiko Okuyama, Hideya Hyodo, Yasuko Hamada, Kazuo Dan, Lieping Chen, Kiyoyuki Ogata
Journal: Blood (2011)
One Antigen HLA-Mismatched Related and 8/8 Allele Matched Unrelated Donors Are Associated with Similar Survival after Hematopoietic Cell Transplantation for Acute Leukemia.
Authors: David Valcarcel, Fangyu Kan, Tao Wang, Stephanie J. Lee, Stephen R Spellman, Gregory A. Hale, Susana Marino, David Marks, Philip L. McCarthy, Machteld Oudshoorn, Effie W Petersdorf, Olle Ringdén, Michelle Setterholm, Jorge Sierra
Journal: Blood (2008)
Pretreatment with Anti-CD3 Monoclonal Antibody Depletes Recipient CCR7+ Dendritic Cells and Prevents Graft-Versus-Host Disease While Preserving GVL Effects,
Authors: Can Liu, Wei He, Xiaofan Li, Heather F Johnston, Miao Wang, Jeremy Racine, Paul J Martin, Stephen Forman, Defu Zeng
Journal: Blood (2011)
Radiation Resistance of Double Knockout (DKO) Smad3-/- Fancd2-/- (129/Sv) Mouse Bone Marrow Stromal Cell Lines
Authors: Kevin Keppel, Michael W. Epperly, Donna Shields, Wen Hou, Darcy Franicola, Zhang Xichen, Renee Fisher, Joel S. Greenberger
Journal: Blood (2016)
Inhibition of HDACs and Aminopeptidases Is Highly Synergistic in Myeloma Cells Resulting in Cell Death Via the Upregulation of BIRC3, a Key Mediator of NF-KappaB Signalling.
Authors: Emma M Smith, Brian A Walker, Emma L Davenport, Lauren I Aronson, David Krige, Leon Hooftman, Alan Drummond, Gareth J Morgan, Faith Davies
Journal: Blood (2009)
Expression Quantitative Trait Loci Reveal Regulatory Regions Important In The Pathogenesis of Multiple Myeloma
Authors: David C Johnson, Niels Weinhold, Tobias Meissner, Brian A Walker, Peter Broderick, Bowang Chen, Daniel Chubb, Per Hoffmann, Christopher P Wardell, Alexander Murison, Ni L Li, Fiona M Ross, Jérôme Moreaux, Asta Försti, Walter Gregory, Faith E Davies, Richard S Houlston, Kari Hemminki, Bernard Klein, Dirk Hose, Hartmut Goldschmidt, Gareth J Morgan
Journal: Blood (2013)
Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health
Authors: Lisa M Olsson, Christine Poitou, Valentina Tremaroli, Muriel Coupaye, Judith Aron-Wisnewsky, Fredrik Bäckhed, Karine Clément, Robert Caesar
Journal: Gut (2019)

The gut microbiota has been implicated in the aetiology of obesity and associated comorbidities. Patients with Prader-Willi syndrome (PWS) are obese but partly protected against insulin resistance. We hypothesised that the gut microbiota of PWS patients differs from that of non-genetically obese controls and correlate to metabolic health. Therefore, here we used PWS as a model to study the role of gut microbiota in the prevention of metabolic complications linked to obesity.
A Phase II Study of Post–Remission Therapy with Azacitidine (AZA) in Patients with AML Post-MDS and High-Risk MDS: A GFM Group Study.
Authors: Claude Gardin, Thomas Prébet, Krimo Bouabdallah, Denis Caillot, Agnès Guerci, Emmanuel Raffoux, Jean Pierre Marolleau, Cecile Pautas, Anne Banos, Chantal Himberlin, Anne-Laure Taksin, Arnaud Pigneux, Xavier Thomas, Tony Jernival, Norbert Vey, Francois Dreyfus, Sylvie Chevret, Herve Dombret, Pierre Fenaux
Journal: Blood (2009)
Genetic Landscape and Clonal Evolution Following 5-Aza Therapy in Patients with High-Risk Myelodysplastic Syndromes
Authors: June Takeda, Yusuke Shiozawa, Yuichi Shiraishi, Yusuke Okuno, Keisuke Kataoka, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Shigeru Chiba, Norio Asou, Hitoshi Kiyoi, Kiyotoshi Imai, Chikara Hirase, Nobuaki Dobashi, Toru Kiguchi, Yasushi Miyazaki, Tomoki Naoe, Hideki Makishima, Satoru Miyano, Seishi Ogawa, Kenichi Yoshida
Journal: Blood (2016)
Transplantation of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors: Robust Engraftment and Rapid Immune Reconstitution In Children with High Risk Leukemia
Authors: Rupert Handgretinger, Peter Lang, Tobias F. Feuchtinger, Michael Schumm, Heiko-Manuel Teltschik, Ansgar S Schulz, Volker Huppert, Lorenzo Moretta, Alesandro Moretta, Maria Ester Bernardo, Maurizio Caniglia, Alice Bertaina, Francesco Zinno, Franco Locatelli
Journal: Blood (2011)
Phase II Trial of Oral Panobinostat (LBH589) in Patients with Refractory Cutaneous T-Cell Lymphoma (CTCL).
Authors: Madeleine Duvic, Jürgen C. Becker, Stephane Dalle, Francisco Vanaclocha, Maria Grazia Bernengo, Celeste Lebbé, Reinhard Dummer, Samit Hirawat, Lei Zhang, Miriam Marshood, Glen Laird, H. Miles Prince
Journal: Blood (2008)
Mass Cytometry Analysis Of Myelofibrosis and Secondary Acute Myeloid Leukemia Reveals Constitutive and Cytokine Induced Signaling Abnormalities With Differential Sensitivities To Ruxolitinib
Authors: Daniel A.C. Fisher, Gregory K. Behbehani, Garry P. Nolan, Sean C. Bendall, Stephen T. Oh
Journal: Blood (2013)
Expansion of γδT Cells By New Generation IMiDs and Their Cytotoxicity Against Myeloma Progenitors
Authors: Hirokazu Miki, Takeshi Harada, Qu Cui, Asuka Oda, Ariunzaya Bat-Erdene, Hirofumi Tenshin, Ryota Amachi, Ryohei Sumitani, Munenori Uemura, Mamiko Takahashi, Masami Iwasa, Shiro Fujii, Jumpei Teramachi, Shingen Nakamura, Kumiko Kagawa, Shuji Ozaki, Masahiro Abe
Journal: Blood (2016)
Electrochemotherapy for advanced cutaneous angiosarcoma: A European register-based cohort study from the International Network for Sharing Practices of electrochemotherapy (InspECT)
Authors: Luca G Campana, Erika Kis, Krisztina Bottyán, Antonio Orlando, Francesca de Terlizzi, Grammatiki Mitsala, Rosanna Careri, Pietro Curatolo, Marko Snoj, Gregor Sersa, Sara Valpione, Pietro Quaglino, David Mowatt, Matteo Brizio, Hadrian Schepler
Journal: International Journal of Surgery (2019)
Stochastic Modeling of Hematopoietic Stem and Progenitor Cell Barcoding Data from Rhesus Macaques Challenges the Classic Model of Hematopoiesis
Authors: Jason Xu, Samson J. Koelle, Peter Guttorp, Chuanfeng Wu, Cynthia E. Dunbar, Janis L. Abkowitz, Vladimir Minin
Journal: Blood (2016)
Hematologic and Cytogenetic Responses in Imatinib-Resistant Chronic Phase Chronic Myeloid Leukemia Patients Treated with the Dual SRC/ABL Kinase Inhibitor BMS-354825: Results from a Phase I Dose Escalation Study.
Authors: Charles L. Sawyers, Neil P. Shah, Hagop M. Kantarjian, Nicholas Donato, John Nicoll, Stephen A. Bai, Fei Huang, Edwin Clark, Arthur P. DeCillis, Moshe Talpaz
Journal: Blood (2004)
A Novel Hemoglobin-Binding Agent Reduces Plasma Free Hemoglobin and Partially Improves Vascular Function In Murine Hemolytic Anemia
Authors: Nancy J. Wandersee, Timothy C. Flewelen, Anne C. Frei, Deron W. Jones, Dawn Retherford, Sandra L. Holzhauer, Soumya Gokuli, Madelyn S. Hanson, Cheryl A. Hillery, Neil Hogg, Kirkwood A. Pritchard, Hao Xu
Journal: Blood (2010)
High Incidence of Invasive Fungal Infections in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.
Authors: Winnie Ma, Dawn Warkentin, Janice Yeung, John D Shepherd, Yasser Abou Mourad, Clayton Smith, Kevin Song, Donna E. Hogge, Michael J Barnett, Thomas J. Nevill, Stephen H. Nantel, Cynthia L. Toze, Heather J. Sutherland, Donna L. Forrest, Sujaatha Narayanan, Maryse M Power
Journal: Blood (2009)
Orai1: CRACing the Th17 response in AKI
Authors: Sanjeev Noel
Journal: Journal of Clinical Investigation (2019)

A strong Th17 inflammatory response aggravates ischemia reperfusion–induced (IR-induced) acute kidney injury (AKI), tissue fibrosis, and AKI-to–chronic kidney disease (CKD) progression. However, the underlying mechanisms of sustained Th17 activation following AKI and during AKI-to-CKD progression are unclear. In this issue of the JCI, Mehrotra et al. present compelling evidence that the store-operated calcium (Ca2+) channel Orai1 sustains Th17-driven inflammatory response after AKI and drives the AKI-to-CKD transition. Orai1 blockade significantly protected renal function from IR, attenuated high-salt–induced AKI-to-CKD progression in rats, and decreased Th17 response in rat and human T cells. Therapeutic targeting of Orai1 can potentially reduce AKI, AKI-to-CKD progression, and other Th17-driven diseases.
Augmented Expression of WT1-Specific TCR and Inhibition of Mispaired-TCR Formation In TCR-Gene Modified T-Cells Can Concomitantly Be Achieved Using a Novel Retroviral Vector with Silencers for Endogenous TCRs
Authors: Toshiki Ochi, Hiroshi Fujiwara, Sachiko Okamoto, Jun An, Kozo Nagai, Toshiaki Shirakata, Junichi Mineno, Kiyotaka Kuzushima, Hiroshi Shiku, Masaki Yasukawa
Journal: Blood (2010)
Bortezomib [VELCADE™], Pegylated Liposomal Doxorubicin [DOXIL/CAELYX®] and Dexamethasone in the Treatment of Previously Untreated Multiple Myeloma Patients: Impact on Quality-of-Life.
Authors: Andrew Belch, Donna E. Reece, Nizar J. Bahlis, Darrell White, Bruno Teixeira, Fernando Camacho, Richard K. Plante
Journal: Blood (2007)
Bone health in patients with systemic lupus erythematosus
Authors: Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao
Journal: Annals of the Rheumatic Diseases (2019)

The association between systemic lupus erythematosus and other comorbidities has been extensively studied.1 2 Recently, an article written by Orsolini et al published in Annals of the Rheumatic Diseases commented that osteoporosis and fractures are frequently found in patients with systemic lupus erythematosus.3 Orsolini et al ’s article is a timely one and provides the updated concepts to the readers. Some points are discussed here. A cohort study in South Korea conducted by Kim et al reported that the incidence of fractures was higher in patients with systemic lupus erythematosus than those with non-lupus (19 vs 6.5 per 1000 person-years).4 A cohort study in USA conducted by Tedeschi …
Anti-CD45 Ab Pretargeted Radioimmunotherapy Using An Alpha Emitting Radionuclide (213Bi) Delivers Selective Radiation to Human Myeloid Leukemias in a Mouse Xenograft Model and Results in High Rates of Complete Remission and Long Term Survival.
Authors: Aimee L. Kenoyer, Oliver W. Press, Steven I. Park, Tom Back, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, Shani M. Wilbur, Amanda Axtman, Nural Orgun, Yukang Lin, Ajay K. Gopal, Jaideep Shenoi, Damian J. Green, Frederick R Appelbaum, John M. Pagel
Journal: Blood (2009)
Signal Transducer and Activator Of Transcription 3 Activates and Deregulates Micro RNA Expression In Chronic Lymphocytic Leukemia Cells
Authors: Rozovski Uri, George Calin, Tetsoro Setoyama, Abundu Lucilla, Harris David, Ping Li, Lui Zhiming, Grugurevic Srdana, Alessandra Ferrajoli, Stefan H. Faderl, Jan A. Burger, Susan O'Brien, William G. Wierda, Michael J. Keating, Zeev Estrov
Journal: Blood (2013)
Is There a Benefit of Adding Rituximab to CHOP in the Overall Survival of Patients with B-Cell Non-Hodgkin′s Lymphoma in a Developing Country ?
Authors: Guillermo J. Ruiz-Delgado, David Gomez Almaguer, Luz C. Tarin-Arzaga, Olga Cantú-Rodríguez, Carlos Alarcon-Urdaneta, Uxmal Rodriguez-Morales, Jackeline Calderon-García, Omar Fernandez-Vargas, Maryel Montes-Montiel, Monica Sanchez-Cardenas, Guillermo J. Ruiz-Arguelles
Journal: Blood (2012)
Reduced-Intensity and Non-Myeloablative Allogeneic Stem Cell Transplantation from Alternative HLA-Mismatched Donors for Hodgkin's Lymphoma: A Study By the SFGM-TC (Francophone Society of Bone Marrow Transplantation and Cellular Therapy)
Authors: Jordan Gauthier, Luca Castagna, Federico Garnier, Thierry Guillaume, Gerard Socie, Sebastien Maury, Natacha Maillard, Reza Tabrizi, Tony Marchand, Jean Valere Malfuson, Anne-Claire Gac, Emmanuel Gyan, Melanie Mercier, Yves Beguin, Jeremy Delage, Pascal Turlure, Ambroise Marçais, Stephanie Nguyen, Remy Dulery, Jacques Olivier Bay, Anne Huynh, Etienne Daguindau, Caroline Régny, Mauricette Michallet, Regis Peffault De La Tour, Ibrahim Yakoub-Agha, Didier Blaise
Journal: Blood (2016)
Dual-Function Anti-CD47mAbs Induce Tumor Cell Death and Promote Phagocytosis Resulting in Enhanced in Vivo Efficacy
Authors: Pamela T. Manning, Benjamin J. Capoccia, Michael P. Rettig, Ronald R. Hiebsch, Robert W. Karr, John F. DiPersio, William A. Frazier
Journal: Blood (2014)
Combination of the KSP Inhibitor ARRY-520 with Bortezomib or Revlimid Causes Sustained Tumor Regressions and Significantly Increased Time to Regrowth in Models of Multiple Myeloma.
Authors: Richard Woessner, Brian Tunquist, April Cox, Sumeet Rana, Duncan Walker, Patrice A. Lee
Journal: Blood (2009)
Elevations in MR Measurements of Whole Brain and Regional Cerebral Blood Flow and Oxygen Extraction Fraction Suggest Cerebral Metabolic Stress in Children with Sickle Cell Disease Unaffected By Overt Stroke
Authors: Melanie E. Fields, Kristin P. Guilliams, Dustin Ragan, Cihat Eldeniz, Michael Binkley, Monica L. Hulbert, Katie D. Vo, Robert McKinstry, Joshua Shimony, Hongyu An, Andria Ford, Jin-Moo Lee
Journal: Blood (2015)
Clinical Prognostic Factors in Chemosensitive Multiple Myeloma (MM) Patients Intensified with High Dose Therapy/Stem Cell Support (HDT/SCS): Results of the Spanish Trial (PETHEMA/GEM2000).
Authors: María-Victoria Mateos, Juán-José Lahuerta, Anna Sureda, Javier de la Rubia, Ramón García-Sanz, Rafael Martínez, José García-Laraña, Felipe de Arriba, Jose-María Ribera, Miguel-Teodoro Hernández, Lourdes Escoda, Dolores Carrera, Joan Besalduch, B. Hernández, P. Fernández, Joan Blade, J.F. San Miguel
Journal: Blood (2007)
A Multi-Center, Phase-2 Trial of Losartan for the Nephropathy of Sickle Cell Anemia
Authors: Charles T. Quinn, Santosh L. Saraf, Victor R. Gordeuk, Courtney D. Fitzhugh, Susan E Creary, Prasad Bodas, Alex George, Ashok Raj, Alecia C. Nero, Catherine Terrell, Lisa McCord, Omar Niss, Rubina Dosani, Michael D. Taylor, Prasad Devarajan, Punam Malik
Journal: Blood (2016)
Issues in the Adoption of Robotic Surgery—Reply
Authors: Kyle H. Sheetz, Justin B. Dimick
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Weight Gain in the First 10 Days after Hematopoietic Stem Cell Transplantation (HSCT) Is a Risk Factor for Early Mortality
Authors: Lucila Nassif Kerbauy, Erika MM Costa, Juliano Cordova Vargas, Claudia Mac Donald Bley Nascimento, Joyce E Hyppolito, Ricardo Helman, Alessandro de Moura Almeida, Jose Mauro Kutner, Juliana Folloni Fernandes, Andreza Alice Feitosa Ribeiro, Iracema Esteves, Eduardo Cerello Chapchap, Guilherme Fleury Perini, Paulo Vidal Campregher, Jairo Sobrinho, Claudio Galvão de Castro Junior, Breno Moreno Gusmão, Fabio R. Kerbauy, Nelson Hamerschlak, Fabio P S Santos
Journal: Blood (2014)
Long-Term Outcome of Ruxolitinib Treatment in Patients with Myelofibrosis: Durable Reductions in Spleen Volume, Improvements in Quality of Life, and Overall Survival Advantage in COMFORT-I
Authors: Srdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael W.N. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson-Viitanen, William Sun, Victor A. Sandor, Hagop M. Kantarjian
Journal: Blood (2012)
Phase I Study of the PARP1-2 Inhibitor Veliparib in Combination with Bortezomib in Patients with Relapsed or Refractory Multiple Myeloma
Authors: Paola Neri, Peter Duggan, Kathy Gratton, Li Ren, Jordan Johnson, Jiri Slaby, Douglas A. Stewart, Jonathan J Keats, Nizar J. Bahlis
Journal: Blood (2012)
Expression of MYC, IgM, As Well As Non-Germinal Centre B-Cell Like Immunophenotype and Positive Immunofish Index Predict a Worse Progression Free Survival and Overall Survival in a Series of 670 De Novo Diffuse Large B-Cell Lymphomas Included in Clinical Trials: A GELA Study of the 2003 Program
Authors: Thierry Jo Molina, Josette Brière, Christiane Copie-Bergman, Tony Petrella, Danielle Canioni, Richard Delarue, Peggy Cuillière-Dartigues, Karim Belhadj, Bettina Fabiani, Frederic Peyrade, Marie Parrens, Olivier Fitoussi, Nicolas Ketterer, Christian Recher, Maryse Baia, Jean-François Emile, Philippe Ruminy, Corinne Haioun, Karen Leroy, Gilles Salles, Jean-Philippe Jais, Herve Tilly, Fabrice Jardin, Philippe Gaulard
Journal: Blood (2012)
BCR-ABL Mutations in Chronic Myeloid Leukemia (CML) Patients (pts) with Failure and Warning to First- and Second-Line Tyrosine Kinase Inhibitor (TKI) Therapy: What Is the Advantage of Next-Generation Sequencing (NGS) over Conventional Sequencing?
Authors: Simona Soverini, Caterina De Benedittis, Fausto Castagnetti, Gabriele Gugliotta, Manuela Mancini, Giorgina Specchia, Domenico Russo, Alessandra Iurlo, Massimiliano Bonifacio, Marzia Salvucci, Tamara Intermesoli, Paolo Avanzini, Sara Galimberti, Bruno Martino, Elena Maino, Anna Rita Scortechini, Katerina Machova Polakova, Giuseppe Saglio, Fabrizio Pane, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli
Journal: Blood (2015)
Inhibition of p38 MAPK by SCIO-469 Suppresses TNF Generation and Promotes CD34+ Cell Survival in an In Vitro MDS Cell Culture Model.
Authors: Tony A. Navas, Aaron N. Nguyen, Jing Y. Ma, Elizabeth G. Stebbins, Edwin Haghnazari, Ruth Heaton, Alan F. List, Linda S. Higgins
Journal: Blood (2004)
Reduced Intensity Hematopoietic Cell Transplantation in Active Disease AML Is Associated with Leukemia Free Survival and Relapse Comparable to Myeloablative Conditioning
Authors: Se young Han, Rizwan Romee, Michael Slade, Pavan Kumar Bhamidipati, John F DiPersio, Peter Westervelt, Ravi Vij, Yu Tao
Journal: Blood (2016)
Secondary Chromosomal Abnormalities Appear to Be Less Prognostic for Children with Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with Intensified Imatinib and Chemotherapy: Results of the Children's Oncology Group (COG) Study AALL0031.
Authors: Andrew J. Carroll, Nyla A. Heerema, Meenakshi Devidas, W. Paul Bowman, Chenguang Wang, Michael Trigg, Bruce Camitta, Paul S. Gaynon, Naomi J. Winick, Stephen P Hunger, William L. Carroll, Kirk R. Schultz
Journal: Blood (2009)
Pomalidomide Plus Dexamethasone (Pd) in the Treatment of Asian Patients with Relapsed/Refractory Myeloma (RRMM) Who Are Previously Treated with Bortezomib and Refractory to Lenalidomide - Interim Analysis of a Trial By the Asian Myeloma Network (AMN)
Authors: Wee J Chng, Kihyun Kim, Jeffrey Huang, Chor Sang Chim, Hiroshi Kosugi, Naoki Takezako, Junichi Sakamoto, Sathish Kumar Gopalakrishnan, Yuan Wei, Ling Ying Zhuo, Je-Jung Lee, Sung-Soo Yoon, Jin Seok Kim, Chang-Ki Min, Jae-Hoon Lee, Brian G M Durie
Journal: Blood (2016)